–
Maze Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY22:
FY23:
–
FY24:
76.0
FY25:
−112
Change from FY22 to FY25
millions USD
FY22:
−3.17
FY23:
−0.44
FY24:
−1.15
FY25:
−171
Change from FY24 to FY25
millions USD
FY22:
–
FY23:
–
FY24:
92.8
FY25:
275
(positive)
Change from FY22 to FY25
millions USD
FY22:
−101
FY23:
−87.3
FY24:
74.8
FY25:
−113
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.